Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.8341
+0.0227 (2.80%)
Feb 24, 2026, 10:30 AM EST - Market open
Evogene Market Cap
Evogene has a market cap or net worth of $7.27 million as of February 24, 2026. Its market cap has decreased by -27.49% in one year.
Market Cap
7.27M
Enterprise Value
10.10M
1-Year Change
-27.49%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $7.27M, a decrease of -74.06%. That is a compound annual growth rate of -7.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 23, 2026 | 7.27M | -11.58% |
| Dec 31, 2025 | 8.22M | -36.78% |
| Dec 31, 2024 | 13.00M | -69.10% |
| Dec 31, 2023 | 42.08M | 60.85% |
| Dec 29, 2022 | 26.16M | -63.27% |
| Dec 30, 2021 | 71.23M | -58.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XTL Biopharmaceuticals | 8.19M |
| BiomX | 8.14M |
| Liminatus Pharma | 8.09M |
| CalciMedica | 7.80M |
| Moleculin Biotech | 7.57M |
| Alzamend Neuro | 7.49M |
| Mustang Bio | 7.30M |
| Kiora Pharmaceuticals | 7.26M |